Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia
Elaine Coustan‐Smith(St. Jude Children's Research Hospital), Dario Campana(National University of Singapore), Bassem I. Razzouk(Peyton Manning Children’s Hospital at St.Vincent), Raul C. Ribeiro(St. Jude Children's Research Hospital), José Sancho(St. Jude Children's Research Hospital), John T. Sandlund(St. Jude Children's Research Hospital), Gaston K. Rivera(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Michael L. Hancock(St. Jude Children's Research Hospital), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital)
Cited by 193
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k